Dacopafant
Alternative Names: RP 55778Latest Information Update: 25 Jan 2017
At a glance
- Originator Aventis
- Class Antiasthmatics; Antivirals; Small molecules
- Mechanism of Action Platelet activating factor inhibitors; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; HIV infections; Systemic inflammatory response syndrome
Most Recent Events
- 25 Jan 2017 Discontinued - Phase-I for Asthma (unspecified route)
- 25 Jan 2017 Discontinued - Phase-I for Systemic inflammatory response syndrome (unspecified route)
- 25 Jan 2017 Discontinued - Preclinical for HIV infections treatment in France (unspecified route)